Literature DB >> 18034419

Characterization of mouse CD4 T cell subsets defined by expression of KLRG1.

Niklas Beyersdorf1, Xin Ding, Julia K Tietze, Thomas Hanke.   

Abstract

The mouse killer cell lectin-like receptor G1 (KLRG1) is an inhibitory receptor known to be expressed on a subset of NK cells and antigen-experienced CD8 T cells. Here, we have characterized expression of KLRG1 on CD4+ T cells from normal mice. While a polyclonal TCR repertoire suggests thymic origin of KLRG1+ CD4+ cells, KLRG1 expression was found to be restricted to peripheral CD4+ T cells. Based on phenotypic analyses, a minority of KLRG1+ CD4+ cells are effector/memory cells with a proliferative history. The majority of KLRG1+ CD4+ cells are, however, bona fide Treg cells that depend on IL-2 and/or CD28 and express both FoxP3 and high levels of intracellular CD152. KLRG1-expressing Treg are contained within the CD38+ subset but are only partially overlapping with the CD25+ CD4+ Treg subset. In functional assays, KLRG1+ CD4+ cells were anergic to TCR stimulation with respect to proliferation, and sorted KLRG1+ CD25+ CD4+ cells were equal or superior to KLRG1+ CD25- CD4+ cells, which were more potent than KLRG1- CD25+ CD4+ cells in suppressing responder cell proliferation. Together, our results demonstrate that KLRG1 expression defines novel and distinctive subsets of senescent effector/memory and potent regulatory CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034419     DOI: 10.1002/eji.200737126

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Karsten Kretschmer; Harald von Boehmer; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 2.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

3.  Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling.

Authors:  Cindy Banh; Céline Fugère; Laurent Brossay
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113

4.  Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.

Authors:  Sharyn Tauro; Phuong Nguyen; Bofeng Li; Terrence L Geiger
Journal:  Eur J Immunol       Date:  2013-04-09       Impact factor: 5.532

5.  Lifelong training improves anti-inflammatory environment and maintains the number of regulatory T cells in masters athletes.

Authors:  Luciele G Minuzzi; Luis Rama; Nicolette C Bishop; Fátima Rosado; António Martinho; Artur Paiva; Ana M Teixeira
Journal:  Eur J Appl Physiol       Date:  2017-04-08       Impact factor: 3.078

6.  KLRG1 impairs regulatory T-cell competitive fitness in the gut.

Authors:  Holger Meinicke; Anna Bremser; Maria Brack; Klaudia Schrenk; Hanspeter Pircher; Ana Izcue
Journal:  Immunology       Date:  2017-06-20       Impact factor: 7.397

7.  Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice.

Authors:  Holger Meinicke; Anna Bremser; Maria Brack; Paulina Akeus; Claire Pearson; Samuel Bullers; Katrin Hoffmeyer; Marc P Stemmler; Marianne Quiding-Järbrink; Ana Izcue
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

Review 8.  Regulatory T Cells for More Targeted Immunosuppressive Therapies.

Authors:  Hazim Allos; Basmah S Al Dulaijan; John Choi; Jamil Azzi
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

9.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

10.  Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints.

Authors:  Junko Nishio; Markus Feuerer; Jamie Wong; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.